litigation

News

Colorado's pathfinder medicine price-cap move stalls

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on blockbuster immunology drug Enbrel.

News

SCOTUS backs generic firm Hikma in skinny label dispute

SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.

News

Novo Nordisk fight with KBP Bio will go to arbitration

Singapore court keeps an asset freeze on KBP Bio, saying the merits of its dispute with Novo Nordisk over a licensing deal must go to arbitration.

News

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

Takeda is on the hook for $885m damages – which could rise to $2.5bn – in a suit claiming it paid a rival to delay the launch of a generic competitor.

News

SCOTUS won't hear pharma's IRA complaints

The US Supreme Court has refused to consider lawsuits from pharma groups challenging Medicare's drug pricing negotiation powers.

News

SCOTUS retains telemedicine access to abortion pill

The Supreme Court of the US has ruled that abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order – for now.

Colorado's pathfinder medicine price-cap move stalls

SCOTUS backs generic firm Hikma in skinny label dispute

Novo Nordisk fight with KBP Bio will go to arbitration

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

SCOTUS won't hear pharma's IRA complaints

SCOTUS retains telemedicine access to abortion pill

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

litigation

Editor's Picks